BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16505474)

  • 1. Membrane fusion by single influenza hemagglutinin trimers. Kinetic evidence from image analysis of hemagglutinin-reconstituted vesicles.
    Imai M; Mizuno T; Kawasaki K
    J Biol Chem; 2006 May; 281(18):12729-35. PubMed ID: 16505474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.
    Günther-Ausborn S; Schoen P; Bartoldus I; Wilschut J; Stegmann T
    J Virol; 2000 Mar; 74(6):2714-20. PubMed ID: 10684287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of membrane fusion sites. A total internal reflection fluorescence microscopy study of influenza hemagglutinin-mediated membrane fusion.
    Hinterdorfer P; Baber G; Tamm LK
    J Biol Chem; 1994 Aug; 269(32):20360-8. PubMed ID: 8051131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.
    Danieli T; Pelletier SL; Henis YI; White JM
    J Cell Biol; 1996 May; 133(3):559-69. PubMed ID: 8636231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density.
    Ellens H; Bentz J; Mason D; Zhang F; White JM
    Biochemistry; 1990 Oct; 29(41):9697-707. PubMed ID: 2271610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
    Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
    J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.
    Clague MJ; Schoch C; Blumenthal R
    J Virol; 1991 May; 65(5):2402-7. PubMed ID: 1850019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
    J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a membrane fusible drug carrier from erythrocytes by the spontaneous transfer of viral fusion protein from influenza virus-infected cells.
    Kogure K; Okuda O; Itoh T; Hayashi K; Ueno M
    Biol Pharm Bull; 1997 May; 20(5):581-3. PubMed ID: 9178945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion.
    Bentz J
    Biophys J; 2000 Jan; 78(1):227-45. PubMed ID: 10620288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stochastic fusion simulations and experiments suggest passive and active roles of hemagglutinin during membrane fusion.
    Lee DW; Thapar V; Clancy P; Daniel S
    Biophys J; 2014 Feb; 106(4):843-54. PubMed ID: 24559987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events.
    Blumenthal R; Sarkar DP; Durell S; Howard DE; Morris SJ
    J Cell Biol; 1996 Oct; 135(1):63-71. PubMed ID: 8858163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
    Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.
    Takeda M; Leser GP; Russell CJ; Lamb RA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14610-7. PubMed ID: 14561897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis.
    Leikina E; Markovic I; Chernomordik LV; Kozlov MM
    Biophys J; 2000 Sep; 79(3):1415-27. PubMed ID: 10969003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    Kemble GW; Bodian DL; Rosé J; Wilson IA; White JM
    J Virol; 1992 Aug; 66(8):4940-50. PubMed ID: 1629960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
    Nüssler F; Clague MJ; Herrmann A
    Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence.
    Morris SJ; Sarkar DP; White JM; Blumenthal R
    J Biol Chem; 1989 Mar; 264(7):3972-8. PubMed ID: 2917985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes and fusogenic activity of influenza virus hemagglutinin.
    Shangguan T; Siegel DP; Lear JD; Axelsen PH; Alford D; Bentz J
    Biophys J; 1998 Jan; 74(1):54-62. PubMed ID: 9449309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Architecture of the influenza hemagglutinin membrane fusion site.
    Bentz J; Mittal A
    Biochim Biophys Acta; 2003 Jul; 1614(1):24-35. PubMed ID: 12873763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.